PDGFR‐β‐activated ACK 1‐ AKT Signaling Promotes Glioma Tumorigenesis

Author:

Zhang Jiannan1,Chen Tao2,Mao Qin3,Lin Jinbo2,Jia Jun2,Li Shanquan3,Xiong Wenhao3,Lin Yingying4,Liu Zhiqiang2,Liu Xiaoyu5,Zhao Hailiang2,Wang Guisong3,Zheng Duo5,Qiu Shuqi2,Ge Jianwei3

Affiliation:

1. Operation Room, Shanghai Children's Medical CenterSchool of MedicineShanghai Jiaotong University Shanghai200127 People's Republic of China

2. ENT Hospital, Longgang Central HospitalOtolaryngology Institute of Shenzhen UniversityShenzhen Guangdong518116 People's Republic of China

3. Department of NeurosurgeryRenji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai200127 People's Republic of China

4. Institute of Health SciencesShanghai Institutes for Biological Sciences of Chinese Academy of Sciences‐Shanghai Jiao‐Tong University School of Medicine (SJTU‐SM) Shanghai200025 People's Republic of China

5. School of MedicineShenzhen UniversityShenzhen Guangdong518060 People's Republic of China

Funder

National Natural Science Foundation of China

Shanghai Science and Technology Development Fund

Wu Jieping Medical Foundation

China Postdoctoral Science Foundation

Science & Technology Project of Shenzhen Longgang District

Municipal Science and Technology Project of Shenzhen

Science & Technology Innovation Commission of Shenzhen

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3